Sawicki Gregory S, Goss Christopher H
Division of Respiratory Diseases, Boston Children's Hospital, Boston, Massachusetts.
Division of Pulmonary Medicine, Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington.
Pediatr Pulmonol. 2015 Oct;50 Suppl 40(0 40):S74-9. doi: 10.1002/ppul.23244.
Health outcomes for individuals with cystic fibrosis (CF) have dramatically improved in parallel with better organization of clinical care systems, evolution of novel therapeutics, and improvements in diagnosis and screening for CF and CF-related complications. In parallel with these advances has come an increasing complexity and burden of care, leading to challenges with adherence to treatment regimens. As novel therapeutics continue to be developed and introduced to the CF care regimen, there are clear opportunities to refine and personalize care. This can be done by adding comparative effectiveness research to the CF clinical research paradigm and integrating novel technologies in drug delivery and remote monitoring that can facilitate adherence but also reduce the burden of treatment while maintaining efficacy. This review highlights both the challenges of the increasingly complex treatment regimens in CF and the opportunities to advance care by addressing adherence, implementation science, comparative effectiveness, and integration of novel technologies in CF care.
随着临床护理系统的组织更加完善、新型疗法的发展以及囊性纤维化(CF)及其相关并发症诊断和筛查的改进,CF患者的健康状况得到了显著改善。与这些进展同时出现的是护理的复杂性和负担日益增加,导致在坚持治疗方案方面面临挑战。随着新型疗法不断研发并引入CF护理方案,显然有机会优化和个性化护理。这可以通过在CF临床研究范式中增加比较效果研究,并整合药物递送和远程监测方面的新技术来实现,这些技术不仅可以促进依从性,还能在保持疗效的同时减轻治疗负担。本综述强调了CF中日益复杂的治疗方案所带来的挑战,以及通过解决依从性、实施科学、比较效果以及将新技术整合到CF护理中来推进护理的机会。